LUMICKS
banner
lumicks.bsky.social
LUMICKS
@lumicks.bsky.social
Empowering scientists with tools that reveal crucial insights not available before, at the molecular and cellular level | Dynamic single-molecule & Cell Avidity
👌 How to visualize dynamic protein-DNA interactions in real time, including co-localization and diffusion, to uncover critical molecular mechanisms.

Created in collaboration with Prof. Bennett van Houten @benvh123.bsky.social
August 25, 2025 at 2:32 PM
✌ How to leverage standard mammalian cell culture techniques to perform sophisticated single-molecule experiments, eliminating the need for extensive biochemistry expertise.
August 25, 2025 at 2:32 PM
What you'll learn:

👉 How to observe DNA-binding proteins in their natural state, complete with post-translational modifications, revealing insights inaccessible through purified protein assays.
August 25, 2025 at 2:32 PM
Together, let’s advance the development of next-generation cancer immunotherapies.

lumicks.com/cell-avidity...
Avidion
Avidion - The next generation Cell Avidity platform - Ideal for cell therapy candidate screening and large characterization studies.
lumicks.com
August 8, 2025 at 8:43 AM
Avidion is our next-generation Cell Avidity platform. It is ideal for high-throughput screening and characterization of cell therapy candidates. Avidion empowers discoveries across a broad range of immunotherapy research.
August 8, 2025 at 8:43 AM
Cell Avidity measures the combined strength of cell-cell and cell-protein interactions. It provides direct, physiologically relevant insights into binding in its full, dynamic complexity. Cell Avidity bridges the gap between traditional in vitro assays and real-life in vivo functionality.
August 8, 2025 at 8:42 AM
At LUMICKS, we share the mission to accelerate the development of breakthrough immunotherapies. That’s why we’re excited to support the PICI community by providing early access to our 𝗔𝘃𝗶𝗱𝗶𝗼𝗻, our new Cell Avidity platform.
August 8, 2025 at 8:41 AM
Exciting to see the C-Trap in the hands of talented researchers like Spencer! 🎉
August 5, 2025 at 3:02 PM